Many effective strategies exist when it comes to managing specialty drug costs, but a coordinated approach that takes the financial, clinical and pharmacy elements into account is key to achieving a balance between access and spending, according to Telus Health’s Cory Cowan. Cowan, the organization’s director of professional services, told attendees at the 2018 Pharmacy […]
A new program that aims to move community pharmacies away from a transactional relationship with payors to a shared accountability for patient health outcomes is underway, beginning with measuring performance. Moving toward a value-based system is key because Canada currently spends more per capita on health care, on average, than any other country in the […]
Medical plan costs paid by employers are outpacing inflation, according to a new report by Aon. In Canada, however, medical cost inflation is trending down, lower than both the global and North American averages. Aon expects Canadian medical costs to rise by six per cent next year. Factored against average general inflation of 2.1 per cent in 2019, […]
Any decision reached on pharmacare reform in Canada should guarantee the viability of current health benefits plans, according to the Canadian Life and Health Insurance Association in its submission to the advisory council on the implementation of national pharmacare. Jeopardizing current benefits plans could lead to a delay in access to new medicines and could potentially […]
Green Shield Canada is launching a new benefits product, which will focus on drug coverage and mental-health support and eliminate coverage for massage therapy. The new plan, called SMARTspend, will include a managed drug formulary with 100 per cent coverage and no dollar caps, digital mental-health support options, health coaching from pharmacists and dietitians and vision […]
On Sept. 20, the 2018 Halifax Benefits Summit featured insightful sessions on benefits, health and wellness and drug plan trends. With population numbers struggling in the Maritimes, the conference looked at how companies can ensure they’re providing plan members with the best, most competitive benefits options in order to attract and retain talent. Here are some of the highlights of […]
The issue of a national pharmacare program is more nuanced than it may appear at first glance, said Joe Farago during a presentation at the 2018 Halifax Benefits Summit on Sept. 20. “Canadians are starting to change their views,” said Innovative Medicines Canada’s executive director, private payers and investment, during the conference. Farago pointed to a national poll of health-care providers, managers and the […]
Plan sponsors and administrators walk a razor’s edge, striving to ensure members have access to the services they need while also making certain the plan is financially sustainable. Working collaboratively with health-care providers is a critical step, but these partnerships have often proved elusive, delegates heard at the 2018 Halifax Benefits Summit. “There is a disconnect. We […]
Public drug plan spending continued its upward trend in 2016-17, though at a much slower rate rather in 2015-16, according to a new report by the Patented Medicine Prices Review Board. The analysis, which focuses on the public drug plans participating in the National Prescription Drug Utilization Information System initiative, found spending increased just 1.9 per cent in 2016-17, […]
Universal pharmacare is an idea that has been kicking around for decades in Canada. Yet despite numerous studies calling for a universal single-payer pharmacare program to ensure all Canadians have access to prescription drugs, the country’s drug system remains a patchwork of public and private plans. This spring, the House of Commons’ standing committee on […]